What are the major opportunities in the Personalized Medicine Biomarkers market? What are the strategies for the Personalized Medicine Biomarkers market?

For detailed insights on the major opportunities and strategies in the Personalized Medicine Biomarkers market, Read More

How does the Personalized Medicine Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on Personalized Medicine Biomarkers's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Personalized Medicine Biomarkers market growth? SWOT analysis of the Personalized Medicine Biomarkers market.

For detailed insights on the key dynamics influencing the Personalized Medicine Biomarkers market growth and SWOT analysis of the Personalized Medicine Biomarkers industry, Read More

Personalized Medicine Biomarkers Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Personalized Medicine Biomarkers Market Report 2026

Name: Personalized Medicine Biomarkers Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Biomarker Type (Genomic, Proteomics, Metabolic, Other Biomarker Types), By Disease Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications), By Application (Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring), By End Use (Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Personalized Medicine Biomarkers Market Overview

• Personalized Medicine Biomarkers market size has reached to $26.73 billion in 2025

• Expected to grow to $58.8 billion in 2030 at a compound annual growth rate (CAGR) of 17%

• Growth Driver: Rising Prevalence Of Chronic Diseases Driving Growth Of The Market Due To Increasing Need For Targeted Treatments And Precision Diagnostics

• Market Trend: Regulatory Approvals Enhance Advancements In Personalized Medicine

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Medicine Biomarkers Market?

Personalized medicine biomarkers are specific biological indicators that tailor medical treatments to individual patients based on their unique genetic, molecular, or physiological characteristics. These biomarkers can help predict how a patient will respond to a particular drug, enabling doctors to choose the most effective and safest treatment options.

The main types of biomarkers in personalized medicine are genomic, proteomic, metabolic, and others. Genomic biomarkers are specific genes or genetic mutations that help in understanding how diseases develop and progress in individuals. It is used for various disease indications, including oncology, neurology, diabetes, autoimmune diseases, cardiology, and others, for various applications, including early detection or screening, diagnosis, treatment selection, and monitoring. And it caters to various end users, including hospitals and clinics, pharmaceutical and biotechnology companies, diagnostic labs, and others.

Personalized Medicine Biomarkers Market Global Report 2026 Market Report bar graph

What Is The Personalized Medicine Biomarkers Market Size and Share 2026?

The personalized medicine biomarkers market size has grown rapidly in recent years. It will grow from $26.73 billion in 2025 to $31.34 billion in 2026 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to advances in genomic research, rising cancer incidence, growth of targeted therapies, increased use of molecular diagnostics, regulatory support for precision medicine.

What Is The Personalized Medicine Biomarkers Market Growth Forecast?

The personalized medicine biomarkers market size is expected to see rapid growth in the next few years. It will grow to $58.8 billion in 2030 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to expansion of personalized therapeutics, rising demand for early disease detection, growth in pharmacogenomics, increasing investment in biomarker discovery, wider adoption across non-oncology indications. Major trends in the forecast period include rising adoption of precision treatment approaches, increasing use of biomarkers in oncology care, growing integration of companion diagnostics, expansion of predictive and prognostic biomarkers, higher focus on treatment response monitoring.

Book your 30 minutes free consultation with our research experts

Global Personalized Medicine Biomarkers Market Segmentation

1) By Biomarker Type: Genomic, Proteomics, Metabolic, Other Biomarker Types

2) By Disease Indication: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications

3) By Application: Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring

4) By End Use: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users

Subsegments:

1) By Genomic: Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Expression Biomarkers, Epigenetic Biomarkers

2) By Proteomics: Protein Expression Biomarkers, Post-Translational Modification (PTM) Biomarkers, Protein-Protein Interaction Biomarkers, Enzyme Activity Biomarkers

3) By Metabolic: Lipid Biomarkers, Amino Acid Biomarkers, Carbohydrate Biomarkers, Hormone Biomarkers

4) By Other Biomarker Types: Inflammatory Biomarkers, Microbiome Biomarkers, Autoantibody Biomarkers, Extracellular Vesicle Biomarkers

What Is The Driver Of The Personalized Medicine Biomarkers Market?

The growing prevalence of chronic diseases is expected to propel the growth of the personalized medicine biomarkers market going forward. Chronic diseases are long-term medical conditions that progress slowly and persist for a year or more, requiring ongoing medical attention or limiting daily activities. The growing prevalence of chronic diseases is due to unhealthy lifestyle choices, inferior diets, lack of physical activity, and high levels of stress. Personalized medicine biomarkers help tailor treatments for chronic diseases by identifying effective therapies, predicting disease progression, and minimizing adverse effects based on individual genetic and molecular profiles. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based health authority, by 2050, the number of new cancer cases is expected to surpass 35 million, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the growth of the personalized medicine biomarkers industry.

Key Players In The Global Personalized Medicine Biomarkers Market

Major companies operating in the personalized medicine biomarkers market are AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc.

Global Personalized Medicine Biomarkers Market Trends and Insights

Major companies operating in the personalized medicine biomarkers market are focusing on obtaining regulatory approvals such as companion diagnostic approval to enhance precision oncology by rapidly matching patients to targeted therapies. Companion diagnostic approval refers to the regulatory authorization granted by a health authority (such as the FDA) for a diagnostic test that is specifically designed to identify patients who are most likely to benefit from a particular therapeutic product or are at increased risk of adverse reactions. For instance, in August 2024, Illumina, Inc., a US-based biotechnology company, received the Food and Drug Administration (FDA) approval for its cancer biomarker test and two companion diagnostics. The test uses next-generation sequencing (NGS) technology to identify genetic mutations in cancer cells, enabling clinicians to select the most suitable treatments based on individual biomarkers. This approval marks a significant advancement in precision oncology, aiming to improve the speed and accuracy of treatment selection for cancer patients, ultimately enhancing personalized care.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Personalized Medicine Biomarkers Market?

In February 2025, Renovaro Inc., a US-based biotechnology company, merged with BioSymetrics Inc. to enhance AI-driven biomarker discovery and precision medicine. The merger aims to enhance drug development and create more personalized treatment strategies, addressing complex diseases through innovative, data-driven approaches. BioSymetrics Inc. is a Canada-based phenomics-driven drug discovery company integrating clinical and experimental data using machine learning to advance precision medicine.

Regional Insights

North America was the largest region in the personalized medicine biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Medicine Biomarkers Market?

The personalized medicine biomarkers market consists of sales of biomarker-based diagnostic kits, reagents, testing platforms, epigenetic biomarkers, companion diagnostics, predictive biomarkers, prognostic biomarkers, and multi-omics biomarkers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Personalized Medicine Biomarkers Market Report 2026?

The personalized medicine biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Personalized Medicine Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$31.34 billion
Revenue Forecast In 2035	$58.8 billion
Growth Rate	CAGR of 17.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Biomarker Type, Disease Indication, Application, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElm
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Personalized Medicine Biomarkers Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Personalized Medicine Biomarkers Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Personalized Medicine Biomarkers Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Personalized Medicine Biomarkers Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Precision Treatment Approaches

4.2.2 Increasing Use Of Biomarkers In Oncology Care

4.2.3 Growing Integration Of Companion Diagnostics

4.2.4 Expansion Of Predictive And Prognostic Biomarkers

4.2.5 Higher Focus On Treatment Response Monitoring

5. Personalized Medicine Biomarkers Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Pharmaceutical Companies

5.3 Biotechnology Companies

5.4 Diagnostic Laboratories

5.5 Research Institutions

6. Personalized Medicine Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Medicine Biomarkers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Personalized Medicine Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Personalized Medicine Biomarkers Market Size, Comparisons And Growth Rate Analysis

7.3. Global Personalized Medicine Biomarkers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Personalized Medicine Biomarkers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Medicine Biomarkers Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Medicine Biomarkers Market Segmentation

9.1. Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genomic, Proteomics, Metabolic, Other Biomarker Types

9.2. Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications

9.3. Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring

9.4. Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users

9.5. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Expression Biomarkers, Epigenetic Biomarkers

9.6. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Expression Biomarkers, Post-Translational Modification (PTM) Biomarkers, Protein-Protein Interaction Biomarkers, Enzyme Activity Biomarkers

9.7. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lipid Biomarkers, Amino Acid Biomarkers, Carbohydrate Biomarkers, Hormone Biomarkers

9.8. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inflammatory Biomarkers, Microbiome Biomarkers, Autoantibody Biomarkers, Extracellular Vesicle Biomarkers

10. Personalized Medicine Biomarkers Market Regional And Country Analysis

10.1. Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Medicine Biomarkers Market

11.1. Asia-Pacific Personalized Medicine Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Medicine Biomarkers Market

12.1. China Personalized Medicine Biomarkers Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Medicine Biomarkers Market

13.1. India Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Medicine Biomarkers Market

14.1. Japan Personalized Medicine Biomarkers Market Overview

14.2. Japan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Medicine Biomarkers Market

15.1. Australia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Medicine Biomarkers Market

16.1. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Medicine Biomarkers Market

17.1. South Korea Personalized Medicine Biomarkers Market Overview

17.2. South Korea Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Medicine Biomarkers Market

18.1. Taiwan Personalized Medicine Biomarkers Market Overview

18.2. Taiwan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Medicine Biomarkers Market

19.1. South East Asia Personalized Medicine Biomarkers Market Overview

19.2. South East Asia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Medicine Biomarkers Market

20.1. Western Europe Personalized Medicine Biomarkers Market Overview

20.2. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Medicine Biomarkers Market

21.1. UK Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Medicine Biomarkers Market

22.1. Germany Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Medicine Biomarkers Market

23.1. France Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Medicine Biomarkers Market

24.1. Italy Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Medicine Biomarkers Market

25.1. Spain Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Medicine Biomarkers Market

26.1. Eastern Europe Personalized Medicine Biomarkers Market Overview

26.2. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Medicine Biomarkers Market

27.1. Russia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Medicine Biomarkers Market

28.1. North America Personalized Medicine Biomarkers Market Overview

28.2. North America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Medicine Biomarkers Market

29.1. USA Personalized Medicine Biomarkers Market Overview

29.2. USA Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Medicine Biomarkers Market

30.1. Canada Personalized Medicine Biomarkers Market Overview

30.2. Canada Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Medicine Biomarkers Market

31.1. South America Personalized Medicine Biomarkers Market Overview

31.2. South America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Medicine Biomarkers Market

32.1. Brazil Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Medicine Biomarkers Market

33.1. Middle East Personalized Medicine Biomarkers Market Overview

33.2. Middle East Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Medicine Biomarkers Market

34.1. Africa Personalized Medicine Biomarkers Market Overview

34.2. Africa Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Medicine Biomarkers Market Regulatory and Investment Landscape

36. Personalized Medicine Biomarkers Market Competitive Landscape And Company Profiles

36.1. Personalized Medicine Biomarkers Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Personalized Medicine Biomarkers Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Personalized Medicine Biomarkers Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Medicine Biomarkers Market Other Major And Innovative Companies

Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc.

38. Global Personalized Medicine Biomarkers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Medicine Biomarkers Market

40. Personalized Medicine Biomarkers Market High Potential Countries, Segments and Strategies

40.1 Personalized Medicine Biomarkers Market In 2030 - Countries Offering Most New Opportunities

40.2 Personalized Medicine Biomarkers Market In 2030 - Segments Offering Most New Opportunities

40.3 Personalized Medicine Biomarkers Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Personalized Medicine Biomarkers Market, Overview Of Key Products - Product Examples

Table 2: Global Personalized Medicine Biomarkers Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Personalized Medicine Biomarkers Market, Supply Chain Analysis

Table 4: Global Personalized Medicine Biomarkers Market, Major Raw Material Providers

Table 5: Global Personalized Medicine Biomarkers Market, Major Resource Providers

Table 6: Global Personalized Medicine Biomarkers Market, Major Manufacturers (Suppliers)

Table 7: Global Personalized Medicine Biomarkers Market, Major Distributors And Channel Partners

Table 8: Global Personalized Medicine Biomarkers Market, Key Technologies & Future Trends

Table 9: Global Personalized Medicine Biomarkers Market, Major Trends

Table 10: Global Personalized Medicine Biomarkers Market, Major End Users

Table 11: Global Personalized Medicine Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Personalized Medicine Biomarkers Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Personalized Medicine Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Personalized Medicine Biomarkers Market - TAM, US$ Billion, 2025

Table 15: Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Personalized Medicine Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Personalized Medicine Biomarkers Market - Company Scoring Matrix

Table 99: AbbVie Inc. Financial Performance

Table 100: Bristol-Myers Squibb Company Financial Performance

Table 101: Thermo Fisher Scientific Inc. Financial Performance

Table 102: Abbott Laboratories Financial Performance

Table 103: Novartis AG Financial Performance

Table 104: Global Personalized Medicine Biomarkers Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Personalized Medicine Biomarkers Market, Competitive Dashboard

Table 106: Global Personalized Medicine Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Personalized Medicine Biomarkers Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Table 108: Global, Personalized Medicine Biomarkers Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Table 109: Global, Personalized Medicine Biomarkers Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Personalized Medicine Biomarkers Market, Overview Of Key Products - Product Examples

Figure 2: Global Personalized Medicine Biomarkers Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Personalized Medicine Biomarkers Market, Supply Chain Analysis

Figure 4: Global Personalized Medicine Biomarkers Market, Major Raw Material Providers

Figure 5: Global Personalized Medicine Biomarkers Market, Major Resource Providers

Figure 6: Global Personalized Medicine Biomarkers Market, Major Manufacturers (Suppliers)

Figure 7: Global Personalized Medicine Biomarkers Market, Major Distributors And Channel Partners

Figure 8: Global Personalized Medicine Biomarkers Market, Key Technologies & Future Trends

Figure 9: Global Personalized Medicine Biomarkers Market, Major Trends

Figure 10: Global Personalized Medicine Biomarkers Market, Major End Users

Figure 11: Global Personalized Medicine Biomarkers Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Personalized Medicine Biomarkers Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Personalized Medicine Biomarkers Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Personalized Medicine Biomarkers Market - TAM, US$ Billion, 2025

Figure 15: Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Personalized Medicine Biomarkers Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Personalized Medicine Biomarkers Market - Company Scoring Matrix

Figure 99: AbbVie Inc. Financial Performance

Figure 100: Bristol-Myers Squibb Company Financial Performance

Figure 101: Thermo Fisher Scientific Inc. Financial Performance

Figure 102: Abbott Laboratories Financial Performance

Figure 103: Novartis AG Financial Performance

Figure 104: Global Personalized Medicine Biomarkers Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Personalized Medicine Biomarkers Market, Competitive Dashboard

Figure 106: Global Personalized Medicine Biomarkers Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Personalized Medicine Biomarkers Market Size Gain ($ Billion), Segmentation By Biomarker Type, 2025 – 2030

Figure 108: Global, Personalized Medicine Biomarkers Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Figure 109: Global, Personalized Medicine Biomarkers Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Clinical Biomarkers Market Report 2026 - Global Outlook – By Offering (Product, Service), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immuno...

Personalized Medicine Market Report 2026 - Global Outlook – By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Applicati...

Cancer Biomarker Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Profiling Technologies (Omics Technologies, Immunoassay, Bioinformatics, Cytoge...

Biomarker Discovery Outsourcing Services Market Report 2026 - Global Outlook – By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints), By Discovery Phase (Biomarker Identification,...

Oncology Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Biomarker Types), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer,...

Genomics Personalized Health Market Report 2026 - Global Outlook – By Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing), By Technology (NGS P...

Cardiac Biomarkers Market Report 2026 - Global Outlook – By Biomarker Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA)), By Location Of Testin...

Frequently Asked Questions

How big is the Personalized Medicine Biomarkers Market?

The Personalized Medicine Biomarkers market was valued at $26.73 billion in 2025, increased to $31.34 billion in 2026, and is projected to reach $58.8 billion by 2030.

What is the Personalized Medicine Biomarkers market growth?

The global Personalized Medicine Biomarkers market is expected to grow at a CAGR of 17.0% from 2026 to 2035 to reach $58.8 billion by 2035.

Who are the key players in Personalized Medicine Biomarkers market?

Some Key Players in the Personalized Medicine Biomarkers market Include, AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc. .

What is the anticipated growth trend for the Personalized Medicine Biomarkers market?

Major trend in this market includes: Regulatory Approvals Enhance Advancements In Personalized Medicine. For further insights on this market. request a sample here

Which region has the most growth potential in the Personalized Medicine Biomarkers market?

North America was the largest region in the personalized medicine biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized medicine biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.